22nd International Conference of FFC - 10th International Symposium of ASFFBC

Functional Foods and Chronic Diseases: Science and Practice

September 22-23, 2017, at Harvard Medical School, Boston, MA, USA


Main Conference Topics/Sessions

Session: Functional Food Definition and the Status of Functional Foods in Japan, China, USA and other Countries

  • The regulations, policy, and labeling of functional foods in Japan 
  • Weaknesses and strong points of FOSHU/Food for Special Health Usage
  • The regulations, policy, and labeling of functional foods in China 
  • What is the status of Functional Foods in the USA? Expert opinions from NIH, USDA, and FDA
  • How the new definition of Functional Foods can help to improve the status of functional foods word wide

Session: Functional Foods and Obesity

  • Epidemiology of obesity
  • The modern mechanisms of obesity; energy metabolism and obesity; neurobiological mechanisms of obesity; microbiological mechanisms of obesity; pathophysiologic mechanisms of obesity
  • Biomarkers of obesity
  • The effects of functional food and bioactive compounds on biomarkers of obesity
  • Medical foods for obesity

Session: Functional Foods and Diabetes

  • Epidemiology of diabetes
  • The modern mechanisms of diabetes
  • Biomarkers of diabetes
  • The effects of functional food and bioactive compounds on biomarkers of diabetes
  • Medical foods for diabetes

Session: Functional Foods and Neurological Diseases

  • Epidemiology of mental and neurological diseases
  • Mechanisms of neurological diseases
  • Biomarkers of different mental and neurological diseases
  • The effects of functional food and bioactive compounds on biomarkers of neurological diseases
  • Functional foods for mental and neurological diseases 
  • Medical foods for neurological diseases

Session: Functional Foods and Cardiovascular Diseases (CVD)

  • Epidemiology of CVD
  • Biomarkers of different cardiovascular diseases
  • The effects of functional food and bioactive compounds on biomarkers of cardiovascular diseases
  • Medical foods for CVD

Session: Functional Foods and Cancer

  • Epidemiology of Cancer
  • Biomarkers of different types of cancer
  • The effects of functional food and bioactive compounds on biomarkers of different types of cancer
  • Medical Foods for the Cancer

Session: Functional Foods with Bioactive Compound(s): Prevention and Management of Non-communicable Diseases

  • Functional foods and other non-communicable diseases
  • Bioactive compounds and other non-communicable diseases
  • The effects of medical food on biomarkers of non-communicable diseases

Session: Safety of the Bioactive Compounds and Functional Foods

  • Food-Drug Interactions
  • Safety of bioactive compounds at efficacious levels
  • Safety of  functional foods at efficacious levels
  • Regulatory issues and health claims

Session: Biomarkers and Functional Food

  • Biomarkers and functional foods
  • Biomarkers available for assessing diet-related changes
  • How can biomarkers improve functional food products development process?
  • The importants of Monitoring Miomarkers in Functional food Science
  • FDA’s Biomarker Qualification Program and creation of new functional foods

Special Session: Functional Food, Microbiome and Cancer. Session Chair: Gabriela Riscuta MD, CNS, Program Director, Nutritional Science Research Group, Division of Cancer Prevention, National Cancer Institute, NIH, Bethesda, MD, USA

Special Session: Dietary Exosomes and their Cargos. Session Chair: Janos Zempleni, PhD, Willa Cather Professor of Molecular Nutrition, Director of the Nebraska Center for the Prevention of Obesity Diseases through Dietary Molecules, Director of the Nebraska Gateway to Nutrigenomics, Department of Nutrition and Health Sciences, University of Nebraska-Lincoln, Lincoln, NE, USA

  • DietaryRNAs and non-coding RNAs
  • Dietary exosomes 
  • MicroRNAs from foods
  • MicroRNAs are bioactive compounds
  • Bioavailability of MicroRNAs

Special Session: Nanotechnology for drug and bioactive compounds delivery systems. Session Chair: Rangel-Vázquez, PhD, Research Professor at Technological Institute of Aguascalientes (ITA), Mexico 

Special Session: Functional Food, Microbiome and Cancer: Session Chair: Gabriela Riscuta MD, CNS, Program Director, Nutritional Science Research Group, Division of Cancer Prevention, National Cancer Institute, NIH, Bethesda, MD, USA

  • Definition of a ‘healthy’ gut microbiome
  • Diet and the intestinal microbiome
  • Probiotics and intestinal immunomodulation
  • Microbiome and Cancer

Special session: Engineering bioaccessibility and bioavailability of bioactive compounds. Session Chair: Uri Lesmes, PhD, Associate Professor, Head of the Laboratory of Food Chemistry and Bioactives, Department of Biotechnology and Food Engineering, Technion - Israel Institute of Technology, Haifa, Israel

  • Food structuring and bioaccessibility/ bioavailability
  • Edible delivery systems for bioactive compounds
  • Micro- and nano-encapsulation
  • Impact of processing technologies/conditions on bioaccessibility/ bioavailability
  • Underlying mechanisms of  bioaccessibility/ bioavailability

Session: Current Research and Development of New Functional Food Products.

  • Incentives for functional food research and development
  • Consumer acceptance of functional food products
  • Functional food composition and dietary intake databases
  • Food vehicles for delivery bioactive compounds
  • Research, development and marketing of new functional food products